Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutralizing Antibody Level After COVID-19 Vaccination in Hospital Works.

NCT05083026 is registered in ClinicalTrials.gov with Kyungpook National University Hospital as lead sponsor.

NCT NCT05083026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05083026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutralizing Antibody Level After COVID-19 Vaccination in Hospital Works.
Lead sponsor
Kyungpook National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 2, 2021
Completion date
December 31, 2024
Enrollment
51 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19